Login
Navigate Fool.com
Will STEM beat
the market?

STEMCELLS, INC. (NASDAQ: STEM)

Community Rating: 2 Stars: Unattractive

1.73 -0.01 (-0.29%)

REAL-TIME: Last trade at

Extended Hours: $1.77 $0.04 (2.31%)
Quote as of (NASDAQ)


company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.72
Previous Close $1.74
Daily Range $1.67 - $1.75
52-Week Range $1.15 - $2.43
Market Cap $96.0M
P/E Ratio -2.99
Dividend (Yield) $0.00 (0.0%)
Volume 1,160,686
Average Daily Volume 4,948,825
Current FY EPS -$0.56

How do you think STEM
will perform against the market?

Top STEM Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted April 30, 2014

Wow, two hold-my-nose green thumbs on stem cell stocks in one day. Looks like the tide has been running out on this malodorous little corner of the biopharma sector since Athersys became the latest of … More

5 Replies Reply Report this Post
 

G8BigBoom (< 20)
Submitted March 18, 2009

10 years down the road you will be kicking yourselves for not buying this. On second thought so will I. The technology has shown some very interesting Possible innovations. Talk only goes so far if yo … More

3 Replies Reply Report this Post

News & Commentary

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

Sector Update: Health Care Stocks Falling Late; StemCells Declines Over 10% On Plans for $20 Mln Sto

Sector Update: Health Care Stocks Falling Late; StemCells Declines Over 10% On Plans for $20 Mln Stock Sale

Sector Update: Health Care

Stock Downgrades: Declare Your Independence From Regado Biosciences

Wall Street ratings agencies set the tone for today's stock market.

Medical Action Industries Leads Healthcare Sector; Aerie Pharmaceutical Meets Clinical Endpoints

General Mills Tumbles On Downbeat Earnings; Barnes & Noble Shares Spike Higher

Mid-Afternoon Market Update: Oracle Shares Fall; Shire Shares Climb

Mid-Day Market Update: Oracle Drops On Downbeat Results; Shire Shares Climb

New State-Sponsored Stem Cell Study Launches for Alzheimer’s Disease

Geron Earnings: An Early Look

Let's look forward to this company's next earnings report.

See More STEM News...

Sector

Healthcare

Industry

Drugs

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks